NCT06023771 Invasive Intervention of Local Complications of Acute Pancreatitis
| NCT ID | NCT06023771 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking Union Medical College Hospital |
| Condition | Acute Pancreatitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-10 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-10 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Strategies for invasive intervention in acute pancreatitis include sequential or combined use of multiple drainage and debridement modalities. The more widely used is the step-up approach, which requires an individualized and multidisciplinary (internal medicine, interventional radiology, endoscopy, surgery, critical care medicine, and nutritionists) approach. The available evidence from randomized controlled studies is from highly selected subject populations, and it is unclear whether the results can be applied to complex clinical situations in real clinics, and the optimal strategy for drainage of peripancreatic lesions in different patients still needs to be evaluated in the real world. This study intends to establish a prospective single-center cohort for real-world analysis to collect comprehensive clinic information and clinical outcomes, to evaluate the effectiveness and safety of existing intervention strategies, especially the timing and modality of interventions, in real-world clinical practice, and to explore the key factors affecting patient prognosis.
Eligibility Criteria
Inclusion Criteria: * Admission diagnosis of acute pancreatitis; * Localized complications confirmed by imaging examinations; * Voluntary participation in the study and signing of an informed consent form. Exclusion Criteria: * Improved with conservative treatment without invasive interventions for local complications during hospitalization.
Contact & Investigator
Dong Wu
PRINCIPAL INVESTIGATOR
Peking Union Medical College Hospital
Frequently Asked Questions
Who can join the NCT06023771 clinical trial?
This trial is open to participants of all sexes, studying Acute Pancreatitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06023771 currently recruiting?
Yes, NCT06023771 is actively recruiting participants. Contact the research team at wudong@pumch.cn for enrollment information.
Where is the NCT06023771 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06023771 clinical trial?
NCT06023771 is sponsored by Peking Union Medical College Hospital. The principal investigator is Dong Wu at Peking Union Medical College Hospital. The trial plans to enroll 100 participants.